- Home
- ARVN vs MLAB Comparison
ARVN vs MLAB Comparison
Compare ARVN & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- MLAB
- Stock Information
- Founded
- ARVN 2015
- MLAB 1982
- Country
- ARVN United States
- MLAB United States
- Employees
- ARVN N/A
- MLAB N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- MLAB Industrial Machinery/Components
- Sector
- ARVN Health Care
- MLAB Industrials
- Exchange
- ARVN Nasdaq
- MLAB Nasdaq
- Market Cap
- ARVN 614.8M
- MLAB 680.0M
- IPO Year
- ARVN 2018
- MLAB N/A
- Fundamental
- Price
- ARVN $6.13
- MLAB $120.10
- Analyst Decision
- ARVN Buy
- MLAB Hold
- Analyst Count
- ARVN 19
- MLAB 2
- Target Price
- ARVN $21.14
- MLAB $140.00
- AVG Volume (30 Days)
- ARVN 3.3M
- MLAB 40.7K
- Earning Date
- ARVN 05-01-2025
- MLAB 05-30-2025
- Dividend Yield
- ARVN N/A
- MLAB 0.53%
- EPS Growth
- ARVN N/A
- MLAB N/A
- EPS
- ARVN N/A
- MLAB N/A
- Revenue
- ARVN $426,900,000.00
- MLAB $237,747,000.00
- Revenue This Year
- ARVN N/A
- MLAB $13.48
- Revenue Next Year
- ARVN N/A
- MLAB $4.74
- P/E Ratio
- ARVN N/A
- MLAB N/A
- Revenue Growth
- ARVN 498.74
- MLAB 11.68
- 52 Week Low
- ARVN $5.94
- MLAB $83.68
- 52 Week High
- ARVN $37.38
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- ARVN 31.46
- MLAB 50.42
- Support Level
- ARVN $6.51
- MLAB $116.81
- Resistance Level
- ARVN $7.05
- MLAB $131.20
- Average True Range (ATR)
- ARVN 0.58
- MLAB 4.57
- MACD
- ARVN -0.13
- MLAB 1.19
- Stochastic Oscillator
- ARVN 1.37
- MLAB 42.01
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.